2017 Annual Meeting | C42 - Cerebrovascular Disease II: Hemorrhagic Stroke

Date Sunday 04/23/17

Time 01:00 PM - 03:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Philip B. Gorelick, MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should be able to discuss key diagnostic and management recommendations for IPH and SAH, discuss key scientific guidance recommendations for diagnosis and management of IPH and SAH, and discuss the role of endovascular therapies and recent clinical trial data in diagnosis and management of IPH and SAH.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Other, Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Event Timeline
01:00 PM - 01:35 PM	Speaker	Evidence-based Diagnosis and Management of Intraparenchymal Hemorrhage Venkatesh Aiyagari, MD
01:35 PM - 01:45 PM	Q&A	Questions and Answers Venkatesh Aiyagari, MD
01:45 PM - 02:20 PM	Speaker	Evidence-based Diagnosis and Management of Aneurysmal Subarachnoid Hemorrhage Sean D. Ruland, MD
02:20 PM - 02:30 PM	Q&A	Questions and Answers Sean D. Ruland, MD
02:30 PM - 02:55 PM	Speaker	Aspirin: Benefits and Bleeding Risks Philip B. Gorelick, MD, MPH, FAAN
02:55 PM - 03:00 PM	Q&A	Questions and Answers Philip B. Gorelick, MD, MPH, FAAN

Faculty Disclosures
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Venkatesh Aiyagari, MD	Dr. Aiyagari has received publishing royalties from a publication relating to health care.
Sean D. Ruland, MD	Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up to Date. Dr. Ruland has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Law Firms.

��ɫ��

��ɫ��